Myopia Control

Kurtin Vision Specialists will be one of the first to offer Essilor Stellest

FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia Today, the U.S. Food and Drug Administration authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, commonly referred to as nearsightedness, with or without astigmatism and to slow the progression of the disease in children 6 to 12 years old at the initiation of treatment.

New studies show .05% Atropine effective on slowing Myopia

The only FDA approved way to correct vision while sleeping without surgery.

Orthokeratology Sleep your way to better vision